CareTrust REIT (NYSE:CTRE - Get Free Report) had its price target cut by equities research analysts at Mizuho from $45.00 to $44.00 in a research report issued on Monday, Benzinga reports. The firm presently has an "outperform" rating on the stock. Mizuho's price objective suggests a potential upside of 16.22% from the company's previous close.
Several other research firms also recently weighed in on CTRE. Citigroup reiterated a "market outperform" rating on shares of CareTrust REIT in a research report on Tuesday, October 13th. Wedbush set a $44.00 price objective on shares of CareTrust REIT in a research note on Tuesday, October 13th. JPMorgan Chase & Co. started coverage on CareTrust REIT in a research note on Friday, October 16th. They issued a "neutral" rating and a $41.00 price target for the company. Citizens Jmp reissued a "market outperform" rating and set a $44.00 target price on shares of CareTrust REIT in a research note on Monday. Finally, Wells Fargo & Company increased their target price on CareTrust REIT from $43.00 to $44.00 and gave the company an "overweight" rating in a research report on Monday. Eleven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $43.50.
Get Our Latest Analysis on CTRE
CareTrust REIT Stock Down 0.6%
CTRE stock traded down $0.21 during trading on Monday, hitting $37.86. 582,096 shares of the stock traded hands, compared to its average volume of 2,604,084. The stock has a market cap of $9.75 billion, a price-to-earnings ratio of 23.79 and a beta of 0.77. CareTrust REIT has a 1 year low of $34.74 and a 1 year high of $43.62. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.08 and a quick ratio of 3.08. The firm's 50 day moving average is $37.19 and its two-hundred day moving average is $39.02.
CareTrust REIT (NYSE:CTRE - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.17). CareTrust REIT had a net margin of 59.18% and a return on equity of 8.08%. The business had revenue of $176.36 million for the quarter. On average, sell-side analysts anticipate that CareTrust REIT will post 2.08 EPS for the current year.
Institutional Trading of CareTrust REIT
Several institutional investors and hedge funds have recently bought and sold shares of the business. BlackRock Inc. purchased a new stake in shares of CareTrust REIT during the 2nd quarter valued at approximately $1,643,290,000. Deutsche Bank AG purchased a new position in shares of CareTrust REIT during the second quarter worth $143,963,000. Bank of New York Mellon Corp acquired a new stake in shares of CareTrust REIT in the second quarter valued at $102,162,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in CareTrust REIT by 35,170.9% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,411,896 shares of the company's stock worth $56,970,000 after acquiring an additional 1,407,893 shares in the last quarter. Finally, Legal & General Group Plc acquired a new position in CareTrust REIT in the 2nd quarter valued at about $46,866,000. 87.77% of the stock is currently owned by institutional investors and hedge funds.
CareTrust REIT Company Profile
(
Get Free Report)
CareTrust REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties, with a focus on skilled nursing facilities and senior housing. Its portfolio also includes assisted living and other properties that serve older adults and people requiring healthcare services. The company primarily works with healthcare operators through long-term property leases and other real estate investments. CareTrust's properties are located across the United States, and the company has expanded its investments into the United Kingdom.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CareTrust REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareTrust REIT wasn't on the list.
While CareTrust REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.